ErbB-2 kinase is required for constitutive STAT 3 activation in malignant human lung epithelial cells

International Journal of Cancer

Volumn 83, Issue 4, 1999, Pages 564-570

  Fernandes, Audrey ^a,b   Hamburger, Anne W ^b   Gerwin, Brenda I ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR RECEPTOR; GROWTH FACTOR RECEPTOR; STAT3 PROTEIN; TRANSFORMING GROWTH FACTOR ALPHA;

ARTICLE; CANCER SURVIVAL; ENZYME ACTIVITY; HUMAN; HUMAN CELL; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION;

BENZOTHIAZOLES; CELL LINE; CELL NUCLEUS; DIMERIZATION; DNA-BINDING PROTEINS; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ENZYME ACTIVATION; ENZYME INHIBITORS; EPITHELIAL CELLS; HUMANS; IMMUNOBLOTTING; LUNG NEOPLASMS; MILK PROTEINS; PRECIPITIN TESTS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RECEPTOR, ERBB-2; STAT1 TRANSCRIPTION FACTOR; STAT3 TRANSCRIPTION FACTOR; STAT5 TRANSCRIPTION FACTOR; TRANS-ACTIVATORS; TRANSFECTION; TRANSFORMING GROWTH FACTOR ALPHA; TYRPHOSTINS;

EID: 0032852374     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19991112)83:4<564::AID-IJC20>3.0.CO;2-Q     Document Type: Article

References (31)

1. BEERLI, R.R., WELS, W. and HYNES, N.E., Autocrine inhibition of the epidermal growth factor receptor by intracellular expression of a single-chain antibody. Biochem. biophys. Res Comm., 204, 666-672 (1994).
2. BESTWICK, R.K., KOZAK, S.L. and KABAT, D., Overcoming interference to retroviral superinfection results in amplified expression and transmission of cloned genes. Proc. nat. Acad. Sci (Wash.), 85, 5404-5408 (1988).
3. BROMBERG, J.F., HORVATH, C.M., BESSER, D., LATHEM, W.W. and DARNELL, J.E., STAT 3 activation is required for cellular transformation by v-src. Mol. cell Biol., 18, 2553-2558 (1998).
4. DAVID, M., WONG, L., FLAVELL, R., THOMPSON, S.A., WELLS, A., LARNER, A.C. and JOHNSON, G.R., STAT activation by epidermal growth factor (EGF) and amphiregulin. Requirement for the EGF receptor kinase but not for tyrosine phosphorylation sites or JAK1. J. biol Chem., 271, 9185-9188 (1996).
5. FERNANDES, A.M., HAMBURGER, A.W. and GERWIN, B.I., Production of EGF related ligands in tumorigenic and benign human lung epithelial cells. Cancer Lett., 142, 55-63 (1999).
6. FONTANINI, G. and 13 others, Evaluation of epidermal growth factor-related growth factors and receptors and of neoangiogenesis in completely resected stage I-IIIA non-small-cell lung cancer: amphiregulin and microvessel count are independent prognostic indicators of survival. Clin. Cancer Res., 4, 241-249 (1998).
7. GARCIA, R., Yu, C.L., HUDNALL, A., CATLETT, R., NELSON, K.L., SMITHGALL, T., FUJITA, D.J., ETHIER, S.P. and JOVE, R., Constitutive activation of STAT 3 in fibroblasts transformed by diverse oncoproteins and in breast carcinoma cells. Cell Growth Differentiation, 8, 1267-1276 (1997).
8. GRANDIS, J.R., DRENNING, S.D., CHAKRABORTY, A., ZHOU, M.Y., ZENG, Q., PITT, A.S. and TWEARDY, D.J., Requirement of STAT 3 but not Stat 1 activation for epidermal growth factor receptor-mediated cell growth in vitro. J. din. Invest., 102, 1385-1392 (1998).
9. HAMBURGER, A.W., FERNANDES, A., MURAKAMI, M. and GERWIN, B.I., The role of transforming growth factor alpha production and ErbB-2 overexpression in induction of tumorigenicity of lung epithelial cells. Brit. J. Cancer., 77, 1066-1071 (1998).
10. HYNES, N.E. and STERN, D.F., The biology of erbB-2/neu/HER-2 and its role in cancer. Biochim. biophys. Acta, 1198, 165-184 (1994).
11. IHLE, J.N., WITTHUHN, B.A., QUELLE, F.W., YAMAMOTO, K., THIERFELDER, W.E., KREIDER, B. and SILVENNOINEN, O., Signaling by the cytokine receptor superfamily: JAKs and STATs. Trends biochem. Sci., 19, 222-227 (1994).
12. KARUNAGARAN, D., TZAHAR, E., BEERLI, R.R., CHEN, X., GRAUS-PORTA, D., RATZKIN, B.J., SEGER, R., HYNES, N.E. and YARDEN, Y., ErbB-2 is a common auxiliary subunit of NDF and EGF receptors: implications for breast cancer. EMBO J., 15, 254-264 (1996).
13. KERN, J.A., SCHWARTZ, D., NORDBERG, J.A., WEINER, D.B., GREENE, M.I., TORNEY, L. and ROBINSON, R.A., p185neu expression in human lung adenocarcinomas predicts shortened survival. Cancer Res., 50, 5184-5191 (1990).
14. KOKAI, Y., DOBASHI, K., WEINER, D.B., MYERS, J.N., NOWELL, P.C. and GREENE, M.I., Phosphorylation process induced by epidermal growth factor alters the oncogenic and cellular neu (NGL) gene products. Proc. natl. Acad. Sci (Wash.), 85, 5389-5393 (1988).
15. LEVITZKI, A. and GAZIT, A., Tyrosine kinase inhibition: an approach to drug development. Science, 267, 1782-1787 (1995).
16. MCNEIL, C., Herceptin raises its sights beyond advanced breast cancer. J. natl. Cancer Inst., 90, 882-883 (1998).
17. NG, J. and CANTRELL, D., STAT 3 is a serine kinase target in T lymphocytes. Interleukin 2 and T cell antigen receptor signals converge upon serine 727. J. biol Chem., 272, 24542-24549 (1997).
18. NOGUCHI, M., MURAKAMI, M., BENNETT, W., LUPU, R., HUI, F., JR., HARRIS, C.C. and GERWIN, B.I., Biological consequences of overexpression of a transfected c-erbB-2 gene in immortalized human bronchial epithelial cells. Cancer Res., 53, 2035-2043 (1993).
19. OLAYIOYE, M.A., GRAUS-PORTA, D., BEERLI, R.R., ROHRER, J., GAY, B. and HYNES, N.E., ErbB-1 and ErbB-2 acquire distinct signaling properties dependent upon their dimerization partner. Mol. cell Biol., 18, 5042-5051 (1998).
20. OSHEROV, N., GAZIT, A., GILON, C. and LEVITZKI, A., Selective inhibition of the epidermal growth factor and HER2/neu receptors by tyrphostins. J. biol. Chem., 268, 11134-11142 (1993).
21. QIAN, X., DOUGALL, W.C., HELLMAN, M.E. and GREENE, M.I. Kinase-deficient neu proteins suppress epidermal growth factor receptor function and abolish cell transformation. Oncogene, 9, 1507-1514 (1994).
22. QIU, Y., RAVI, L. and KUNG, H.J. Requirement of ErbB2 for signalling by interleukin-6 in prostate carcinoma cells. Nature (Lond.), 393, 83-85 (1998).
23. REDDEL, R.R., KE, Y., GERWIN, B.I., MCMENAMIN, M.G., LECHNER, J.F., SU, R.T., BRASH, D.E., PARK, J.B., RHIM, J.S. and HARRIS, C.C. Transformation of human bronchial epithelial cells by infection with SV40 or adenovirus-12 SV40 hybrid virus, or transfection via strontium phosphate coprecipitation with a plasmid containing SV40 early region genes. Cancer Res., 48, 1904-1909 (1988).
24. SCHAEFER, T.S., SANDERS, L.K., PARK, O.K. and NATHANS, D., Functional differences between STAT3alpha and Stat3beta. Mol. cell Biol., 17, 5307-5316 (1997).
25. SCHREIBER, E., MATTHIAS, P., MULLER, M.M. and SCHAFFNER, W., Rapid detection of octamer binding proteins with "mini-extracts", prepared from a small number of cells. Nucl. Acids Res., 17, 6419-6419 (1989).
26. SLAMON, D.J., GODOLPHIN, W., JONES, L.A., HOLT, J.A., WONG, S.G., KEITH, D.E., LEVIN, W.J., STUART, S.G., UDOVE, J., ULLRICH, A. and PRESS, M.F., Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer. Science, 244, 707-712 (1989).
27. TATEISHI, M., ISHIDA, T., MITSUDOMI, T., KANEKO, S. and SUGIMACHI, K., Prognostic value of c-erbB-2 protein expression in human lung adenocarcinoma and squamous cell carcinoma. Europ. J. Cancer, 27, 1372-1375 (1991).
28. TURKSON, J., BOWMAN, T., GARCIA, R., CALDENHOVEN, E., DE GROOT, R.P. and JOVE, R., Stat3 activation by Src induces specific gene regulation and is required for cell transformation. Mol. cell Biol., 18, 2545-2552 (1998).
29. WELS, W., HARWERTH, I.M., ZWICKL, M., HARDMAN, N., GRONER, B. and HYNES, N.E., Construction, bacterial expression and characterization of a bifunctional single-chain antibody-phosphatase fusion protein targeted to the human erbB-2 receptor. Biotechnology, 10, 1128-1132 (1992).
30. YU, D., WANG, S.S., DULSKI, K.M., TSAI, C.M., NICOLSON, G.L. and HUNG, M.C., c-erbB-2/neu overexpression enhances metastatic potential of human lung cancer cells by induction of metastasis-associated properties. Cancer Res., 54, 3260-3266 (1994).
31. ZHANG, X., BLENIS, J., LI, H.C., SCHINDLER, C. and CHEN-KIANG, S., Requirement of serine phosphorylation for formation of STAT-promoter complexes. Science, 267, 1990-1994 (1995).